Thermo Fisher Scientific Share Price Berne S.E.
Equities
TFS
US8835561023
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
514.5 CHF | -0.35% | -0.35% | +19.58% |
Sales 2024 * | 4.3TCr 3.84TCr 3,59200Cr | Sales 2025 * | 4.61TCr 4.12TCr 3,84900Cr | Capitalization | 22TCr 19TCr 18,15400Cr |
---|---|---|---|---|---|
Net income 2024 * | 614.6Cr 549.17Cr 51TCr | Net income 2025 * | 697.1Cr 622.89Cr 58TCr | EV / Sales 2024 * | 5.6 x |
Net Debt 2024 * | 2.35TCr 2.1TCr 1,96100Cr | Net Debt 2025 * | 1.91TCr 1.71TCr 1,59800Cr | EV / Sales 2025 * | 5.13 x |
P/E ratio 2024 * |
35.8
x | P/E ratio 2025 * |
30.7
x | Employees | - |
Yield 2024 * |
0.26% | Yield 2025 * |
0.29% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | -0.35% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
Director of Finance/CFO | 57 | 01/01/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
C. Harris
BRD | Director/Board Member | 67 | 30/12/30 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01/22/01 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.99% | 19TCr | |
+19.71% | 14TCr | |
+30.60% | 11TCr | |
+0.84% | 6.43TCr | |
+15.23% | 5.29TCr | |
+2.06% | 4.95TCr | |
-5.49% | 3.83TCr | |
-0.22% | 3.52TCr | |
+20.56% | 3.05TCr |
- Stock Market
- Equities
- TMO Stock
- TFS Stock